Complete genome sequence can be ID'd from amniotic fluid

Complete genome sequence can be ID'd from amniotic fluid

(HealthDay)—The complete genome sequence of fetuses can be elucidated from amniotic fluid, according to a study published online March 15 in Clinical Chemistry.

Qing Mao, from Complete Genomics Inc., in San Jose, Calif., and colleagues isolated cellular DNA and cell-free DNA (cfDNA) from the cell pellet of 31 amniocenteses and conducted sequencing to approximately 50× genome coverage. Long fragment read libraries were generated from DNA isolated from cells from a subset of samples, and sequencing was performed to approximately 100× genome coverage.

The researchers found that concordance of variant calls exceeded 96 percent between the two DNA sources and with parental libraries. Two fetal genomes had potentially detrimental variants in chromodomain helicase DNA binding protein 8 and low-density lipoprotein receptor-related protein 1; variations of these have been linked to and keratosis pilaris atrophicans, respectively. For a variety of diseases, drug sensitivities and carrier information of fetuses were discovered.

"We were able to elucidate the of 31 fetuses from and demonstrate that the cfDNA or DNA from the cell pellet can be analyzed with little difference in quality," the authors write. "We believe that current technologies could analyze this material in a highly accurate and complete manner and that analyses like these should be considered for addition to current amniocentesis procedures."

Several authors disclosed financial ties to Complete Genomics Inc.

More information: Abstract
Full Text

Journal information: Clinical Chemistry

Copyright © 2018 HealthDay. All rights reserved.

Citation: Complete genome sequence can be ID'd from amniotic fluid (2018, March 27) retrieved 28 November 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Novel genomics tool enables more accurate identification of rare mutations in cancer cells


Feedback to editors